Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 17;1(1):73-76.
doi: 10.1097/BS9.0000000000000015. eCollection 2019 Aug.

Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing

AiLi Chen  1 , ShaoYan Hu  2 , Qian-Fei Wang  1   3
Affiliations

Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing

AiLi Chen et al. Blood Sci. .

Abstract

Individual tumors comprise genetically and epigenetically heterogeneous subclones, each of which is presumably associated with a distinct function, such as self-renewal or drug sensitivity. The dissection of such intratumoral heterogeneity is crucial to understand how tumors evolve during disease progression and under the selection of therapeutic intervention. As a paradigm of cancer intratumoral heterogeneity and clonal evolution, acute myeloid leukemia (AML) has been shown to possess complex clonal architecture based on karyotype studies, as well as deep sequencing of mixed cellular populations using next-generation sequencing (NGS) technologies. The recent development of single-cell sequencing (SCS) methods provides a powerful tool to allow analysis of genomes, transcriptomes, proteomes, and epigenomes at an individual cell level. The technologies applied in AML have broadened our understanding of AML heterogeneity and provided new insights for the development of novel therapeutic strategies. In this review, we summarize the progress in the research of AML heterogeneity using SCS technology and discuss the limitations and future direction regarding how SCS can contribute to AML prognosis and treatment.

Keywords: Acute myeloid leukemia; Heterogeneity; Single-cell sequencing.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no conflict of interest.

References

    1. Nowell PC. The clonal evolution of tumor cell populations. Science (New York, NY) 1976;194(4260):23–28. - PubMed
    1. Hinohara K, Polyak K. Intratumoral heterogeneity: more than just mutations. Trends Cell Biol 2019;29(7):569–579. - PMC - PubMed
    1. McGranahan N, Swanton C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 2015;27(1):15–26. - PubMed
    1. Wilson NK, Göttgens B. Single-cell sequencing in normal and malignant hematopoiesis. HemaSphere 2018;2(2):e34. - PMC - PubMed
    1. Ley TJ, Miller C, Ding L, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013;368(22):2059–2074. - PMC - PubMed